1. Home
  2. ASLE vs BSX Comparison

ASLE vs BSX Comparison

Compare ASLE & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASLE
  • BSX
  • Stock Information
  • Founded
  • ASLE 2008
  • BSX 1979
  • Country
  • ASLE United States
  • BSX United States
  • Employees
  • ASLE N/A
  • BSX 53000
  • Industry
  • ASLE Industrial Specialties
  • BSX Medical/Dental Instruments
  • Sector
  • ASLE Consumer Discretionary
  • BSX Health Care
  • Exchange
  • ASLE Nasdaq
  • BSX Nasdaq
  • Market Cap
  • ASLE N/A
  • BSX 138.4B
  • IPO Year
  • ASLE N/A
  • BSX 1992
  • Fundamental
  • Price
  • ASLE $6.82
  • BSX $102.39
  • Analyst Decision
  • ASLE Strong Buy
  • BSX Strong Buy
  • Analyst Count
  • ASLE 3
  • BSX 23
  • Target Price
  • ASLE $9.00
  • BSX $110.57
  • AVG Volume (30 Days)
  • ASLE 564.5K
  • BSX 10.5M
  • Earning Date
  • ASLE 05-07-2025
  • BSX 04-23-2025
  • Dividend Yield
  • ASLE N/A
  • BSX N/A
  • EPS Growth
  • ASLE N/A
  • BSX 15.23
  • EPS
  • ASLE 0.11
  • BSX 1.37
  • Revenue
  • ASLE $345,066,000.00
  • BSX $17,554,000,000.00
  • Revenue This Year
  • ASLE $14.51
  • BSX $15.77
  • Revenue Next Year
  • ASLE $18.41
  • BSX $10.33
  • P/E Ratio
  • ASLE $61.36
  • BSX $74.35
  • Revenue Growth
  • ASLE 3.16
  • BSX 19.36
  • 52 Week Low
  • ASLE $4.53
  • BSX $70.97
  • 52 Week High
  • ASLE $9.40
  • BSX $107.17
  • Technical
  • Relative Strength Index (RSI)
  • ASLE 42.71
  • BSX 59.77
  • Support Level
  • ASLE $6.38
  • BSX $92.70
  • Resistance Level
  • ASLE $6.62
  • BSX $102.37
  • Average True Range (ATR)
  • ASLE 0.36
  • BSX 3.73
  • MACD
  • ASLE -0.06
  • BSX 0.98
  • Stochastic Oscillator
  • ASLE 40.00
  • BSX 97.19

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Share on Social Networks: